Biomerica Stock Market Value
| BMRA Stock | USD 0.31 0.01 3.13% |
| Symbol | Biomerica |
Biomerica Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.327 | Quarterly Revenue Growth 0.055 | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biomerica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biomerica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biomerica.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Biomerica on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Biomerica or generate 0.0% return on investment in Biomerica over 720 days. Biomerica is related to or competes with SurModics, Movano, Ainos, Tivic Health, Bone Biologics, Tenon Medical, and Modular Medical. Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeuti... More
Biomerica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biomerica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biomerica upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 25.24 | |||
| Value At Risk | (10.26) | |||
| Potential Upside | 9.38 |
Biomerica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomerica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biomerica's standard deviation. In reality, there are many statistical measures that can use Biomerica historical prices to predict the future Biomerica's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (0.16) |
Biomerica Backtested Returns
Biomerica secures Sharpe Ratio (or Efficiency) of -0.0655, which signifies that the company had a -0.0655% return per unit of risk over the last 3 months. Biomerica exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biomerica's Mean Deviation of 4.2, risk adjusted performance of (0.03), and Standard Deviation of 5.75 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.1, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomerica will likely underperform. At this point, Biomerica has a negative expected return of -0.38%. Please make sure to confirm Biomerica's treynor ratio and the relationship between the skewness and day typical price , to decide if Biomerica performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.85 |
Very good predictability
Biomerica has very good predictability. Overlapping area represents the amount of predictability between Biomerica time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biomerica price movement. The serial correlation of 0.85 indicates that around 85.0% of current Biomerica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.84 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Biomerica lagged returns against current returns
Autocorrelation, which is Biomerica stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biomerica's stock expected returns. We can calculate the autocorrelation of Biomerica returns to help us make a trade decision. For example, suppose you find that Biomerica has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biomerica regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biomerica stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biomerica stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biomerica stock over time.
Current vs Lagged Prices |
| Timeline |
Biomerica Lagged Returns
When evaluating Biomerica's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biomerica stock have on its future price. Biomerica autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biomerica autocorrelation shows the relationship between Biomerica stock current value and its past values and can show if there is a momentum factor associated with investing in Biomerica.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:Check out Biomerica Correlation, Biomerica Volatility and Biomerica Alpha and Beta module to complement your research on Biomerica. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Biomerica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.